UPPER URINARY TRACT UROTHELIAL CARCINOMA
Clinical trials for UPPER URINARY TRACT UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UPPER URINARY TRACT UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UPPER URINARY TRACT UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to stop aggressive urinary tract cancer from coming back
Disease control Recruiting nowThis study tests whether a targeted drug (disitamab vedotin) plus radiation can prevent cancer from returning in people with HER2-positive upper urinary tract cancer who have high risk of recurrence after surgery. About 60 adults will either receive the 6-month combo therapy or s…
Matched conditions: UPPER URINARY TRACT UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New drug duo aims to save kidneys in aggressive urinary tract cancer
Disease control Recruiting nowThis study tests whether two drugs, disitamab vedotin and tislelizumab, given before surgery can help control high-risk upper tract urothelial carcinoma while allowing surgeons to remove only the tumor and keep the kidney. About 20 participants will receive the drugs every 3 week…
Matched conditions: UPPER URINARY TRACT UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New cancer gel targets rare urinary tract tumors without surgery
Disease control Recruiting nowThis study tests a new version of a cancer drug called UGN-104, given directly into the upper urinary tract, for people with low-grade upper tract urothelial cancer. The goal is to see if it can completely eliminate visible tumors and keep the cancer from coming back. About 70 ad…
Matched conditions: UPPER URINARY TRACT UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Can patients with rare kidney cancer safely keep their kidney? major european study seeks answers.
Knowledge-focused Recruiting nowThis study follows 2,500 people with a rare cancer of the kidney's drainage system (UTUC) to see if less invasive, kidney-sparing surgery works as well as removing the whole kidney. Researchers will track survival, cancer return, kidney function, and quality of life over 10 years…
Matched conditions: UPPER URINARY TRACT UROTHELIAL CARCINOMA
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:01 UTC